ARQ-151

· Arcutis Biotherapeutics, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ARQ-151, covering 2023-03-10 to 2026-08-07. Get the full timeline:

Most recent: Clinical Trial Results: Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-216) [Phase 2]